Danaher Co. (NYSE:DHR) is Bourgeon Capital Management LLC's 8th Largest Position

Bourgeon Capital Management LLC trimmed its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 2.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 58,459 shares of the conglomerate's stock after selling 1,719 shares during the quarter. Danaher makes up approximately 2.6% of Bourgeon Capital Management LLC's investment portfolio, making the stock its 8th largest position. Bourgeon Capital Management LLC's holdings in Danaher were worth $11,984,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in DHR. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at about $27,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher during the fourth quarter valued at approximately $31,000. Hurley Capital LLC purchased a new position in shares of Danaher in the fourth quarter valued at approximately $34,000. Pineridge Advisors LLC increased its position in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after purchasing an additional 57 shares in the last quarter. Finally, Rialto Wealth Management LLC acquired a new position in Danaher in the 4th quarter valued at $34,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insider Buying and Selling at Danaher

In related news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman now directly owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a research note on Sunday. Royal Bank of Canada restated an "outperform" rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Robert W. Baird cut their price objective on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. UBS Group lowered their target price on Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Finally, Jefferies Financial Group dropped their price target on Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a research report on Tuesday, April 22nd. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $263.24.

Danaher Trading Down 0.6%

Shares of NYSE DHR traded down $1.16 during trading on Thursday, reaching $191.92. The stock had a trading volume of 3,055,960 shares, compared to its average volume of 3,476,559. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a market cap of $137.35 billion, a P/E ratio of 36.35, a PEG ratio of 2.66 and a beta of 0.80. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The business's 50-day moving average price is $191.68 and its 200-day moving average price is $212.83.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. On average, equities research analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.67%. Danaher's dividend payout ratio (DPR) is presently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.